This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stenner-Liewen, F. Articles by Pfreundschuh, M. Search for Related Content PubMed PubMed Citation Articles by Stenner-Liewen, F. Articles by Pfreundschuh, M.

Definition of Tumor-associated Antigens in Hepatocellular Carcinoma¹

University of the Saarland, Medizinische Klinik I, 66421 Homburg/Saar, Germany [F. S-L., G. L., U. S., O. T., M. K., I. K., H. L., M. P.]; The Burnham Institute, La Jolla, California 92037 [F. S-L.]; and Department of Histology and Embryology, Nanning, Guangxi, 530021, People’s Republic of China [G. L.]

With an estimated annual incidence of about one million cases, hepatocellular carcinoma (HCC) is one of the most common neoplasms worldwide. Of all malignant diseases, it is the major cause of death in some regions of Africa and Asia. The pathogenic mechanisms responsible for HCC are not well defined, and therapeutic means, especially in inoperable HCCs, are still unsatisfactory and await improvement. In the quest for tumor antigens exploitable for gene therapy, we studied immune responses in the context of HCC. A cDNA library derived from a human HCC sample was screened using the SEREX approach. Nineteen distinct antigens reactive with autologous IgG were identified. Sequence analysis revealed three of the cDNA clones to code for hitherto unknown proteins and 16 known genes products. Proteins as diverse in function as LDH, albumin, and kinectin were found. Furthermore, proteins involved in the transcription/translation machinery had elicited an immune response in the autologous host. A panel of allogenic sera including sera from patients with hepatitis, liver cirrhosis, HCC, and other tumor entities, as well as sera from normal individuals, was used for frequency analysis of antibody responses. Whereas allogenic sera of HCC patients detected most antigens at a high percentage, control sera were rarely antibody-positive. The nature of the major fraction of antigens described here are linked to liver. Thus, our findings demonstrate not only the complexity of the humoral immune response against HCC, but may also offer new insight into mechanisms underlying transformation of the liver cell.

This article has been cited by other articles:

				Y. Wang, K.-J. Han, X.-W. Pang, H. A. Vaughan, W. Qu, X.-Y. Dong, J.-R. Peng, H.-T. Zhao, J.-A. Rui, X.-S. Leng, et al. Large Scale Identification of Human Hepatocellular Carcinoma-Associated Antigens by Autoantibodies J. Immunol., July 15, 2002; 169(2): 1102 - 1109. [Abstract] [Full Text] [PDF]

				F. Le Naour, F. Brichory, D. E. Misek, C. Brechot, S. M. Hanash, and L. Beretta A Distinct Repertoire of Autoantibodies in Hepatocellular Carcinoma Identified by Proteomic Analysis Mol. Cell. Proteomics, March 1, 2002; 1(3): 197 - 203. [Abstract] [Full Text] [PDF]